Table 3. Classification of catalog SNPs for alternate summary statistics.
| Median Measurement | First Available Measurement | Maximum Measurement | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lab | Testable Catalog SNPs | Concordant Increased Significance | Concordant Decreased Significance | Discordant Effect | Concordant Increased Significance | Concordant Decreased Significance | Discordant Effect | Concordant Increased Significance | Concordant Decreased Significance | Discordant Effect |
| Chol | 91 | 0 | 12 | 0 | 1 | 11 | 1 | 2 | 4 | 6 |
| Create | 36 | 2 | 0 | 0 | 2 | 2 | 1 | 0 | 8 | 1 |
| EoAB | 31 | 0 | 6 | 0 | 0 | 9 | 0 | 0 | 2 | 1 |
| EoRE | 28 | 0 | 1 | 0 | 0 | 4 | 0 | 0 | 1 | 1 |
| HCT | 36 | 0 | 0 | 0 | 4 | 0 | 1 | 15 | 0 | 1 |
| HDL | 101 | 0 | 6 | 3 | 0 | 15 | 1 | 0 | 27 | 5 |
| Hgb | 34 | 0 | 0 | 0 | 5 | 0 | 0 | 12 | 0 | 0 |
| LDL | 84 | 0 | 9 | 1 | 0 | 9 | 4 | 2 | 2 | 6 |
| LymphAB | 35 | 0 | 0 | 0 | 0 | 3 | 1 | 5 | 1 | 2 |
| LymphRE | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MCHC | 20 | 0 | 1 | 0 | 2 | 5 | 3 | 2 | 5 | 1 |
| MCH | 64 | 0 | 16 | 27 | 0 | 33 | 8 | 0 | 33 | 7 |
| MCV | 77 | 1 | 5 | 7 | 0 | 19 | 13 | 0 | 30 | 6 |
| MonoAB | 43 | 2 | 3 | 0 | 0 | 9 | 0 | 0 | 13 | 1 |
| MPV | 84 | 0 | 11 | 9 | 0 | 39 | 9 | 5 | 20 | 17 |
| PLT | 102 | 0 | 0 | 1 | 7 | 7 | 1 | 0 | 19 | 5 |
| PMNAB | 35 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 3 | 1 |
| PMNRE | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| RBC | 50 | 0 | 4 | 4 | 13 | 0 | 1 | 21 | 0 | 0 |
| RDW | 29 | 0 | 1 | 2 | 0 | 1 | 4 | 0 | 7 | 0 |
| Trigs | 73 | 0 | 7 | 0 | 1 | 15 | 1 | 0 | 22 | 0 |
| WBC | 33 | 0 | 4 | 5 | 0 | 7 | 1 | 0 | 9 | 0 |
| Total | 1127 | 5 (0.4%) | 86 (7.6%) | 59 (5.2%) | 35 (3.1%) | 190 (16.9%) | 51 (4.5%) | 64 (5.6%) | 206 (18.3%) | 62 (5.5%) |